Funding · Company

Hinge Bio, Inc.

Burlingame, CABiotech & Pharma

Hinge Bio, Inc. of Burlingame, CA has disclosed $31M across 1 Form D offering filed with the SEC on Jan 15, 2025.

$31M

Total disclosed

Form D offering

Offerings on file

Each amount is as reported on that filing, cumulative across its own amendments. Newest first.

$31M

Form D · Jan 15, 2025 ↗

Q1 2025 · target $41M

Filing details

HeadquartersBurlingame, CAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001804959Offerings on file1

Links

All SEC filings for this company ↗ hingebio.com ↗ More biotech & pharma raises →

Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →